
Cipher pays $Cdn25.5mm for Cardiome's Canadian business portfolio
Executive Summary
Cipher Pharmaceuticals Inc. is paying $Cdn25.5mm ($19.5mm) to acquire Cardiome Pharma Corp.'s Canadian business portfolio. Cipher will finance the transaction with cash and new debt.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash for Equity
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com